03 / Symptoms Following Discontinuation of Tyrosine Kinase Inhibitor (TKI) Therapy After Achieving an Adequate Response in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
2017 ◽
Vol 35
(5)
◽
pp. 567-567
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. e18024-e18024
◽
2017 ◽
Vol 17
(12)
◽
pp. e71-e73
◽
2014 ◽
Vol 141
(5)
◽
pp. 887-899
◽